Latest P53 Stories
New research links three molecules to a critical tumor suppressor gene that is often turned off in multiple myeloma, a presently incurable cancer of the blood.
Long overshadowed by p53, its famous tumor-suppressing sibling, the p63 gene does the tougher, important job of stifling the spread of cancer to other organs.
LEXINGTON, Ky., Oct. 13 /PRNewswire/ -- Transposagen Biopharmaceuticals, Inc.
New hypothesis in the FASEB Journal suggests balance between NF-kB and p53 signaling is a promising target for new drugs.
Australian and American scientists have found a way of shrinking tumours in certain cancers â€“ a finding that provides hope for new treatments.
St. Jude Children's Research Hospital scientists discovered a new mechanism cells use to maximize production of a key protein following DNA damage and demonstrated the potential of small molecules to regulate the process and protect healthy tissue.
OMAHA, Neb., Sept. 13 /PRNewswire/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) today announced that it completed the requirements for CE IVD labeling and has significantly expanded distribution of its SURVEYORÂ® Scan K-RAS mutation detection kit throughout most of the European Union.
SAN DIEGO, Sept. 2 /PRNewswire/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of ProtandimÂ®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving ProtandimÂ® was published in the scientific journal PLoS ONE.
Study suggests potential for new oncolytic therapies.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have uncovered the genes that regulate MDM2, an oncogene that, in turn, regulates the tumor suppressor protein p53.
- A volcanic mudflow.